GUANGZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company has partnered with Tabuk Pharmaceutical Manufacturing...
Read More Details
Finally We wish PressBee provided you with enough information of ( Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia )
Also on site :
- First cargo leaves LNG Canada
- Kendall Jenner’s Venice Getaway Post Draws Sweet Message from Kris Jenner
- Democratic ‘Thinkers’ Already Plotting Project 2029